Clipmarks - Rosiglitazone Clipmarks

by Matthew Herper 4-8-2008

Glaxo gets a warning letter from the FDA, which says the company didn't provide full and timely information about Avandia. "We take these findings seriously, and corrective steps to make sure we file periodic reports completely and promptly have been taken or are underway," said Dr. Ronald Krall, Chief Medical Officer at GlaxoSmithKline said in a prepared statement. "These omissions did not interfere with the timely reporting of adverse event information to the FDA."

3
POPS Avandia use can lead to brittle bones

by kkcapricorn 12-2-2007

Poor little mice.

0
POPS Rosiglitazone

by sowganya 9-23-2007

Rosiglitazone is an anti-diabetic drug in the thiazolidinedione class of drugs. It is marketed by the pharmaceutical company GlaxoSmithKline as a stand-alone drug and in combination with metformin or with glimepiride.

1
POPS Avandia, Actos Get Heart Failure Warnings

by Forbes Business 8-14-2007

Not a surprise; this side effect is well-known for both of these drugs. Although laypeople often confuse heart failure and heart attacks, they are distinct. Heart failure is when the heart is chronically weak; heart attacks are when muscle tissue in the heart actually dies because it is starved of blood. So this is not the denouement of the Avandia controversy we've been watching for several months now. --Matt Herper

3
POPS Scientists link diabetes drugs to heart failure

by dorine 7-27-2007

Avandia and Actos.

0
POPS Diabetes drug scare

by tron2007 6-14-2007

No Remarks

— end of the list —

Search Results

Rosiglitazone

Search Options